期刊文献+

血清多肽图技术建立子宫内膜异位症诊断模型 被引量:1

Establishment of serum peptidome pattern-based diagnostic model of endometriosis
下载PDF
导出
摘要 目的利用基质辅助激光解析电离飞行时间质谱分析(MALDI-TOF-MS)技术分析血清多肽图,建立子宫内膜异位症(EMs)的血清诊断模型。方法采用MALDI-TOF技术和Clinprotools软件分析21例EMs血清和29例健康对照血清多肽图谱,建立诊断模型。用10例EMs血清和15例健康对照血清进行盲样验证。结果在m/z1000~10000的范围内共得到18个有统计学意义的差异多肽峰(P<0.01),表达上调的多肽有6个,下调的有12个,该模型盲样验证得到90.9%的敏感性和100%的特异性,准确率96.2%。结论可以利用MALDI-TOF-MS技术和Clinprotools软件来筛选子宫内膜异位症标记物。 Objective To establish a diagnostic model of endometriosis by analyzing serum peptidome patterns in patients with endometriosis using matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS).Methods Serum samples from 21 endometriosis patients and 29 healthy control subjects were analyzed using MALDI-TOF-MS and Clinprotools 2.0 software to establish the diagnostic model of endometriosis,which was validated using the serum samples from 10 endometriosis patients and 15 healthy controls.Results Eighteen statistically significant peptide peaks were obtained with the m/z value ranging from 1 000 to 10 000 (P0.01).Among the peaks,12 were down-regulated and 6 up-regulated.The sensitivity and specificity of the model was 90.9% and 100.0% ,respectively,with a diagnostic accuracy of 96.2% .Conclusion This model shows the feasibility of using MALDI-TOF-MS and Clinprotools software to identify the biomarkers of endometriosis.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第4期851-854,共4页 Journal of Southern Medical University
关键词 质谱 磁珠 子宫内膜异位症 血清多肽图 mass spectrometry magnetic beads endometriosis serum peptidome pattern
  • 相关文献

参考文献9

  • 1Carr SA, Celis JE. Biomarkers and clinical proteomics[J]. Mol Cell Proteomics, 2006, 5(10): 17-9.
  • 2Cheng AJ, Chen LC, Chien KY, et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology[ J ]. Clin Chem, 2005, 51 (12): 2236-44.
  • 3Wulfkuhle JD, Liotta LA, Petricoin EF, Proteomic applications for the early detection of cancer [J]. Nat Rev Cancer, 2003, 3 (4): 267-75.
  • 4Eleftherios P. Diamandis mass spectrometry as a diagnostic and a cancer biomarker discovery tool [J]. Mol Cell Proteomics, 2004, 3 (4): 367-78.
  • 5Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer [J ]. Lancet, 2002, 359 (9306): 572-5.
  • 6Campa M J, Wang MZ, Howard B, et al. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin A as potential molecular targets in non-small cell lung cancer [J]. Cancer Res, 2003, 63(7): 1652-6.
  • 7王娜,董方霆,张学敏,李爱玲,王杰,王红霞,李萍,吴胜明,杨晓虹.水热法制备质谱专用提取多肽的金属螯合纳米磁珠[J].化学学报,2007,65(4):344-348. 被引量:5
  • 8Liu H, Lang J, Zhou Q, et al. Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization time-of-fight mass spectrometry [J]. Fertil Steril, 2007, 87(4): 988-90.
  • 9胡芬,张炜,康晓楠,刘银坤.应用SELDI-TOF-MS技术初步建立子宫内膜异位症诊断模型[J].生殖与避孕,2008,28(3):168-173. 被引量:2

二级参考文献28

共引文献5

同被引文献11

  • 1Oertelt S, Rieger R, Selmi C, et al. A sensitive bead assay for antimitochondrial antibodies.. Chipping away at AMA - negative primary biliary cirrhosis [J]. J Hepatol, 2007,45:659 - 665.
  • 2Kita H, Imawari M, Gershwin ME. Cellular immune sponse in primary biliary cirrhosis [ J ]. Hepatol Res, 2004, 28 (1): 12 -17.
  • 3Kaplan MM, Gershwin ME. Primary biliary cirrhosis [J]. N Engl J Med, 2005, 353: 1261 -1273.
  • 4Heathcote EJ . Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines[J]. J Hepatol, 2000, 31: 1005 -1013.
  • 5Carr SA, Celis JE. Biomarkers and clinical proteomics [ J ]. Mol Cell Proteomics, 2006, 5(10): 17-19.
  • 6Leung SM, Mok SC. Quality management of ovarian cancer serum profiles using functionalized magnetic beads, anchorchip TM technology, MALDI -TOF MS and MALDI -TOF - TOF MS/MS[R]. AACR Annual Meeting, 2004.
  • 7Cheng AJ, Chen LC, Chien KY, et al. Oral cancer plasma tumor marker identified with bead -based affinity-fractionated proteomic technology [ J ]. Clin Chem, 2005, 51 (12): 2236 -2244.
  • 8Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer [J]. Nat Rev Cancer, 2003, 3 (4): 267 -275.
  • 9Li YZ, Hu C J, Leng XM, et al. Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI - TOF - MS [J]. Anat Rec, 2009, 292 (3): 455 -460.
  • 10闫惠平.原发性胆汁性肝硬化的临床免疫特征[J].北京医学,2010,32(3):214-215. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部